The US aims to double trade with India to $500 billion in three years as Trump says a trade deal is 'pretty close', ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical ...
US Ambassador Sergio Gor said Washington aims to increase bilateral trade with India from over $240 billion to $500 billion ...
Asianet Newsable on MSN
US sets ambitious goal to double bilateral trade with India to $500B
The US aims to double its bilateral trade with India to over USD 500 billion in three years, says Ambassador Sergio Gor. He ...
BridgeBio Pharma (BBIO) is back in focus after new real world data on its ATTR-CM drug acoramidis showed replicated benefits ...
BridgeBio Pharma (NasdaqGS:BBIO) reported new real world and expanded clinical data for acoramidis in ATTR-CM, showing ...
The Department of Defense awarded a nearly $41 million contract earlier this year to a Singapore-based drug company to develop a novel ketamine product to treat severe pain incurred in battle — but ...
The U.S. is aiming to more than double its trade with India to over $500 billio - U.S. Aims To Push India Trade Beyond $500 ...
Slate Medicines, a Raleigh, North Carolina-based clinical-stage biotechnology company developing treatments for migraine and other headache disorders, has appointed Stephen... Read More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results